Greenwich LifeSciences, Inc. (GLSI) Dividend History

Company News

• Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team

  Greenwich LifeSciences plans to build its internal clinical trial management team for the FLAMINGO-01 Phase III trial, aiming to reduce costs and improve efficiency by hiring dedicated staff and reducing dependence on external Clinical Research Organizations.

  GlobeNewswire Inc.
• Insiders Buying Greenwich LifeSciences And 2 Other Stocks

  Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Harrow The Trade: Harrow, Inc. (NASDAQ: HROW) 10% owner Opaleye Management Inc. ...

  Benzinga

  Featured Companies: BRT HROW
• After Golden Cross, Greenwich LifeSciences, Inc. (GLSI)'s Technical Outlook is Bright

  Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

  Zacks Investment Research